On October 1, 2025, cbdMD, Inc. (NYSE American: YCBD) announced the closing of a $1.7 million Series B Convertible Preferred Private Placement with institutional investors, including C/M Capital Master Fund, LP. The transaction generated gross proceeds of $1.7 million, of which $1.5 million will be used for working capital and general corporate purposes.
The Series B shares carry a 10 % annual dividend and are convertible at the holder’s option into common stock at an initial conversion price of $1.00 per share. A Registration Rights Agreement requires the company to file a registration statement covering the common shares issuable upon conversion, ensuring liquidity for investors.
By bolstering its equity base, the financing supports cbdMD’s efforts to expand distribution for its consumer brands, position the company for sustained profitability, and help regain full listing compliance with NYSE American. The capital raise provides a critical buffer for ongoing strategic initiatives and strengthens the company’s financial footing in a competitive market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.